EMBL Ventures has announced that its portfolio company ViraTherapeutics is set to be acquired by Boehringer...
Up To Date
Latest News
Orphan drug leader Shire plc has been granted EU marketing authorization for its recombinant van Willebrand...
Drug Developers dealing with PD1-PDL1 checkpoint inhibitors must consider new safety problems associated with...
The European Investment Bank (EIB) has issued its first Sustainability Awareness Bond worth €500m to support...
Around 300 international AMR experts met at ESCMID-ASM drug development conference in Lisbon to discuss the...
Oxford-based Adaptimmune Therapeutics plc has raised US$100m in a registered direct offering of American...